Nervelin Disclaimer

That sentence is not decoration and it is not a formality. It is the legal boundary a dietary supplement is sold inside, and it is the reason this website reports what the carton claims rather than asserting anything of its own.

The three lines the front of this carton prints are “supports comfort”, “supports nerve protection”, “supports circulation”. Structure-and-function language of that kind is permitted; disease language is not. This desk reproduces those three lines as what the label says and does not repeat them as findings, because no human trial of any ingredient on this panel has tested a nerve outcome.

The seller ships two marketing panels with the product art whose headlines reach further than the carton does. Both appear on the home page as images, because every supplied asset earns its place, and their wording appears nowhere in this desk’s prose.

A capsule bought without a prescription, from a food category, made by a manufacturer who is responsible for its safety and sold without pre-market review. The federal overview sets that framework out plainly.

• A dietary supplement, not a drug. A capsule — not a gummy and not liquid drops.
• Not intended to diagnose, treat, cure or prevent any disease, and not FDA-approved.
• For healthy adults aged 18 and over, and not during pregnancy or breastfeeding.
• The capsule shell is gelatin, so it is not suitable for a vegetarian or vegan diet.
• Garcinia cambogia appears in a published liver-injury case series, on its own and combined with green tea. Anyone with a liver condition should take that to a clinician before starting a blend that contains it.
• Cinnamon bark carries coumarin, which has its own tolerable daily intake, so a second cinnamon product on top of this one is worth adding up.
• Tongkat Ali and horny goat weed both act on hormone pathways in their trials. Anyone on hormone therapy, a blood thinner or heart medicine should tell their prescriber what is in this blend.
• Numbness, burning or pins and needles that is new, spreading or worse at night is a reason to be assessed rather than a reason to start a capsule.
• Individual results vary. Sleep, blood sugar, alcohol and how much you move affect the same feelings this category is sold for.
• Review scores and order counts on this website are the distributor’s own summary figures, not verified transcripts and not evidence.
• Lot NER-26/GO-5362 and certificate reference NER-5362-26-GO are filing references, not laboratory proof.
• The website email cannot see orders. For a refund, call the order desk.
• The money-back guarantee is a purchase policy, not a medical promise.

Two of those lines carry a named source rather than a general caution. The published liver-injury case series recorded cases associated with Garcinia cambogia alone and combined with green tea, and a review of herbal liver injury sets out why the category is hard to attribute. The coumarin risk assessment is the reason the cinnamon line asks you to count other cinnamon products rather than to worry about this one.

Numbness, burning or pins and needles that is new, spreading or worse at night is a reason to be assessed rather than a reason to start a capsule. The NINDS overview of peripheral neuropathy explains why: the sensation is the symptom and the cause is what decides what helps.

This is the disclaimer that matters most on this particular carton, and it is a fact about labelling law rather than an accusation about the product.

A declaration and a measurement are different objects. A panel is the first one.

The consequence is arithmetic anyone can do. The Tongkat Ali trials ran at 200 mg a day. The Epimedium trial ran at 740 mg a day. The JAMA Garcinia trial ran at 1,500 mg of hydroxycitric acid and found nothing beyond placebo at that amount. The bitter melon trial ran 300 mg and 600 mg for twelve weeks. Four names, at the lower figure each, want 2,740 mg between them, and the blend is 1,000 mg with five more names in it.

That subtraction is on the carton rather than in anybody’s opinion, which is why it appears on the panel page and the ingredients page instead of being softened into a caveat. What it establishes is a ceiling, not a verdict: no row can hold more than the whole blend, and eight rows have to fit in whatever the first one leaves.

Individual results vary, and on this panel there is a further reason why. No trial of this finished blend exists, so nobody has measured what a person taking it should expect, and the buyers on the reviews page are describing satisfaction rather than an outcome.

Nothing on this website promises a result, quantifies one, or sets a date by which anything should have happened. The review figures printed here are the distributor’s own summary rather than verified transcripts, and they are labelled that way wherever they appear.